Skip to content
10-Q

Quarterly Report

Biostar Pharmaceuticals, Inc.

0001185185-17-001230

← back to feed
Filed
May 19, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 15, 2017 2.66M sh
Shares Diluted Q1 2017 · Mar 31, 2017 2.64M sh
Shares Diluted Q1 2017 · Mar 31, 2016 2.21M sh
Operating Cash Flow Q1 2017 · Mar 31, 2017 $321.13K
Operating Cash Flow Q1 2017 · Mar 31, 2016 $342.82K
Short Term Debt Q1 2017 · Mar 31, 2017 $2.34M
Short Term Debt Q1 2017 · Mar 31, 2017 ¥20M
Short Term Debt Q1 2017 · Dec 31, 2016 $2.33M
Short Term Debt Q1 2017 · Dec 31, 2016 ¥20M
Cash And Equivalents Q1 2017 · Mar 31, 2017 $483.86K
Cash And Equivalents Q1 2017 · Dec 31, 2016 $173.29K
Cash And Equivalents Q1 2017 · Mar 31, 2016 $91.48K
Cash And Equivalents Q1 2017 · Dec 31, 2015 $38.9K
Stockholders Equity Q1 2017 · Mar 31, 2017 $36.18M
Stockholders Equity Q1 2017 · Dec 31, 2016 $36.88M
Current Liabilities Q1 2017 · Mar 31, 2017 $5.31M
Current Liabilities Q1 2017 · Dec 31, 2016 $5.62M
Current Assets Q1 2017 · Mar 31, 2017 $6.34M
Current Assets Q1 2017 · Dec 31, 2016 $7.37M
Total Assets Q1 2017 · Mar 31, 2017 $41.49M
Total Assets Q1 2017 · Dec 31, 2016 $42.5M
Eps Diluted Q1 2017 · Mar 31, 2017 −$0.38
Eps Diluted Q1 2017 · Mar 31, 2016 −$0.28
Eps Basic Q1 2017 · Mar 31, 2017 −$0.38
Eps Basic Q1 2017 · Mar 31, 2016 −$0.28
Sga Expense Q1 2017 · Mar 31, 2017 $766.33K
Sga Expense Q1 2017 · Mar 31, 2016 $690.42K
Net Income Q1 2017 · Mar 31, 2017 −$1.01M
Net Income Q1 2017 · Mar 31, 2016 −$620.34K
Operating Income Q1 2017 · Mar 31, 2017 −$1.04M
Operating Income Q1 2017 · Mar 31, 2016 −$668.52K
Gross Profit Q1 2017 · Mar 31, 2017 $0
Gross Profit Q1 2017 · Mar 31, 2016 $344.97K
Cost Of Revenue Q1 2017 · Mar 31, 2017 $0
Cost Of Revenue Q1 2017 · Mar 31, 2016 $456.66K
Revenue Q1 2017 · Mar 31, 2017 $0
Revenue Q1 2017 · Mar 31, 2016 $801.63K